✦ LIBER ✦

OVEREXPRESSION OF BCL-2 SEEN IN RESIDUAL PROSTATE CANCER AFTER NEOADJUVANT CHEMOHORMONAL THERAPY WITH DOCETAXEL FOR LOCALLY ADVANCED PROSTATE CANCER

✍ Scribed by Kumazawa, Teruaki; Tsuruta, Hiroshi; Saito, Mitsuru; Narita, Shintaro; Horikawa, Yohei; Yuasa, Takeshi; Tsuchiya, Norihiko; Satoh, Shigeru; Habuchi, Tomonori

Book ID: 123149681
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)60277-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of Radical Prostatectomy Aft

Feasibility of Radical Prostatectomy After Neoadjuvant Chemohormonal Therapy for Patients With High Risk or Locally Advanced Prostate Cancer: Results of a Phase I/II Study

✍ KONETY, BADRINATH R.; EASTHAM, JAMES A.; REUTER, VICTOR E.; SCARDINO, PETER T.; 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 72 KB

Predictors of Serum Testosterone Normali

Predictors of Serum Testosterone Normalization after Neoadjuvant and Concurrent Androgen Deprivation Therapy in Conjunction with Radiotherapy for Localized Prostate Cancer

✍ M.J. Zelefsky; E. Gorshein; X. Pei; M. Kollmeier; B. Cox; Y. Yamada; Z. Zhang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Surrogate endpoints for prostate cancer-

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

✍ Anthony V D'Amico; Ming-Hui Chen; Mario de Castro; Marian Loffredo; David S Lamb 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 145 KB

Re: Surrogate Endpoints for Prostate Can

Re: Surrogate Endpoints for Prostate Cancer-Specific Mortality After Radiotherapy and Androgen Suppression Therapy in Men With Localised or Locally Advanced Prostate Cancer: An Analysis of Two Randomised Trials

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 113 KB

Commentary on “Surrogate endpoints for p

Commentary on “Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localized or locally advanced prostate cancer: An analysis of 2 randomized trials.” A.V. D'Amico, M.H. Chen, M. de Castro, M. Loffredo, D.S. Lamb, A. Steigler, P.W. Kantoff, J.W. Denham, Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA

✍ Trump, Donald L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Utility of tissue microarrays for profil

Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors

✍ Nariculam, Joseph; Freeman, Alex; Bott, Simon; Munson, Phillipa; Cable, Noriko; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 449 KB